Latest Breaking News On - Directed issue - Page 8 : comparemela.com

15 May 2023 | Stenocare A/S | Company announcement | Inside Information NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Stenocare A/S (“Stenocare” or “the Company”) announces a rights issue of units (the “Issue”) consisting of shares, warrants of series TO1 and warrants of series TO2 (“Units”). The Issue amounts to three transactions, including an imminent share-issue (the “Initial Rights Issue”) and two subsequent warrant exercises of TO1 and TO2 (the “Warrants”), with total gross proceeds of up to 29.7 mDKK.

United kingdomMelsing frederiksenSolural pharmaThomas skovlund schnegelsbergLund elmer sandagerMarianne wierLund elmer sandagerkalvebod bryggeHans wittrupHenrik amilonJeppe bo petersenJonas bruunPeter bugge johansenGerhard dahlPeter nilssonClaus dalsgaardJimmie landermann